Dr Rene Roux is a leading consultant medical oncologist with over 25 years’ experience who specialises in the diagnosis and systemic treatment of breast cancer and gynaecological cancers such as ovarian cancer. As a specialist, Dr Roux is renowned for her expertise and precision in the use of hormone therapy, chemotherapy, and targeted agents (including PARP inhibitors and CDK4/6 inhibitors) for cancer management.
She consults privately at Nuffield Health The Manor Hospital, Oxford, at The Chiltern Hospital, and at GenesisCare Oxford. As well as this, Dr Roux also manages a busy NHS practice at Oxford University Hospitals, where she serves as operational lead and as chair for the systemic anti-cancer treatment service in addition to her consultant duties.
Dr Roux originally qualified from the University of Cape Town in 1997. She then trained in London, in internal medicine at St Mary’s Hospital and in medical oncology at The Royal Marsden, before going on to complete formal research at the prestigious Institute of Cancer Research. Dr Roux accomplished her higher specialist training in medical oncology at The Royal Free, University College Hospital and Mount Vernon Hospital, and was awarded membership to the Royal College of Physicians in 2003. She joined Oxford University Hospitals as a consultant in 2016.
Alongside her clinical practice, Dr Roux is a principal investigator for multiple national and international clinical trails in breast cancer, ovarian cancer, endometrial cancer, and advanced cervical cancer. She is the gynaecological sub-specialty lead for the Thames Valley Cancer Research Network and the appointed oncology lead for the Oxford Specialist Oncology Menopause multidisciplinary team, and is also a member of various professional organisations including the British Gynaecological Cancer Society.